Cited by 185Thyroid Disorders and TreatmentsPharmaceutical Economics and PolicyBiosimilars and Bioanalytical Methods

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

Bioequivalence of Generic and Brand-name Levothyroxine Products in the Treatment of Hypothyroidism

Dong, Betty J.·1997·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1997.03540390035032

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To compare relative bioavailability of Synthroid, Levoxine (Levoxine has been renamed Levoxyl), and 2 generic levothyroxine sodium preparations. DESIGN: Single-blind (primary investigators blinded), randomized, 4-way crossover trial. SETTING: Ambulatory care. PATIENTS: Twenty-two women with hypothyroidism who were clinically and chemically euthyroid and were receiving levothyroxine sodium, 0.1 or 0.15 mg. INTERVENTIONS: All patients received each of the 4 levothyroxine products for 6-week periods in the same dosage as their prestudy regimen with no washout period. The order of the drug sequences was randomly determined before study initiation. MAIN OUTCOME MEASURES: Area under the curve, time to peak serum concentrations, and peak serum concentrations of thyroxine, triiodothyronine, and free thyroxine index for all 4 products. RESULTS: All data analyses were completed prior to unblinding of the product codes. No significant differences between the 4 products were found in area under the curve or peak serum concentrations of total thyroxine, total triiodothyronine, or free thyroxine index. Although Synthroid produced a more rapid rise in total serum triiodothyronine concentration and a higher total peak serum triiodothyronine concentration than the other products, these differences were not statistically significant (P=.08). The Food and Drug Administration criterion for relative bioequivalence within 90% confidence intervals (0.8-1.25) was demonstrated (P<.05) for all pairs of products. Relative bioequivalence of 0.95 to 1.07 was demonstrated, tighter than the current bioequivalence criterion for oral formulations. CONCLUSIONS: The 4 generic and brand-name levothyroxine preparations studied are different but are bioequivalent by current Food and Drug Administration criteria and are interchangeable in the majority of patients receiving thyroxine replacement therapy. Further investigation is required to determine whether our results are equally applicable to all existing levothyroxine preparations.

Integrity signals

Registry

Crossref · 10.1001/jama.1997.03540390035032

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,906
A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
Schuirmann, D. J. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01068419 · Cited by 2,696
Applied Linear Statistical Models.
Barnett, V., Neter, J., & Wasserman, W. (1975) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2984653 · Cited by 2,304
Replacement Dose, Metabolism, and Bioavailability of Levothyroxine in the Treatment of Hypothyroidism
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Levothyroxine Therapy in Patients with Thyroid Disease
Mandel, S. J., Brent, G. A., & Larsen, P. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00009 · Cited by 324
Consideration of individual bioequivalence
Anderson, S., & Hauck, W. W. (1990) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062202 · Cited by 249
Bioequivalence Testing -- A Need to Rethink
Kirkwood, T. B. L., & Westlake, W. J. (1981) · Biometrics · doi:10.2307/2530573 · Cited by 222
Accelerated Bone Loss in Hypothyroid Patients Overtreated with L-Thyroxine
Stall, G. M., Harris, S., Sokoll, L. J., & Dawson-Hughes, B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-265 · Cited by 203
Design and Analysis of Bioavailability and Bioequivalence Studies.
Fearn, T., Chow, S., & Liu, J. P. (1994) · Biometrics · doi:10.2307/2533474 · Cited by 201
The effects of posture on the circulating blood volume
Waterfield, R. L. (1931) · The Journal of Physiology · doi:10.1113/jphysiol.1931.sp002765 · Cited by 101

Show all 24 references

Sorted by citations

Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“(100) using correction for baseline T4 levels and the TSH data obtained during the trial, and found that the LT4 products that seemed to be pharmacokinetically bioequivalent were, in fact, not equivalent therapeutically.”
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Chapter 10: Addressing reporting biases
Egger, M., & Moher, D. (2011) · Cited by 977
Systems to rate the strength of scientific evidence.
West, S. L., King, V., Carey, T. S., Lohr, K. N., Mckoy, N. A., Sutton, S. F., & Lux, L. J. (2002) · PubMed Central · Cited by 873
Data Withholding in Academic Genetics
Campbell, E. G., Clarridge, B. R., Gokhale, M., Birenbaum, L., Hilgartner, S., Holtzman, N. A., & Blumenthal, D. (2002) · JAMA · doi:10.1001/jama.287.4.473 · Cited by 491
Reporting bias in medical research - a narrative review
McGauran, N., Wieseler, B., Kreis, J., Schüler, Y.-B., Kölsch, H., & Kaiser, T. (2010) · Trials · doi:10.1186/1745-6215-11-37 · Cited by 452
Publication and related biases.
Song, Eastwood, Gilbody, Duley, & Sutton (2000) · Health Technology Assessment · doi:10.3310/hta4100 · Cited by 427
BIASES IN THE INTERPRETATION AND USE OF RESEARCH RESULTS
MacCoun, R. J. (1998) · Annual Review of Psychology · doi:10.1146/annurev.psych.49.1.259 · Cited by 436
Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000
Haas, J. S., Phillips, K. A., Gerstenberger, E. P., & Seger, A. C. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-11-200506070-00006 · Cited by 271
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
The Effect of Thyroid Hormone on Skeletal Integrity
Greenspan, S. L., & Greenspan, F. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00016 · Cited by 249
Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors
Blumenthal, D., Campbell, E. G., Gokhale, M., Yucel, R. M., Clarridge, B. R., Hilgartner, S., & Holtzman, N. A. (2006) · Academic Medicine · doi:10.1097/00001888-200602000-00008 · Cited by 213
Problems and Limitations in Conducting Systematic Reviews
Egger, M., Dickersin, K., & Smith, G. D. (2001) · Wiley eBooks · doi:10.1002/9780470693926.ch3 · Cited by 214
Claims of Equivalence in Medical Research: Are They Supported by the Evidence?
Greene, W. L., Concato, J., & Feinstein, A. R. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00006 · Cited by 180
Commercially Funded and United States-Based Research Is More Likely to Be Published; Good- Quality Studies with Negative Outcomes Are Not
Lynch, J. R., Cunningham, M. R. A., Warme, W. J., Schaad, D. C., Wolf, F. M., & Leopold, S. S. (2007) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.f.01152 · Cited by 181
A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism
Colucci, P., Yue, C. S., Ducharme, M., Benvenga, S., Principal Scientist, L. A. C. I., Principal Scientist, L. A. C. I. A. P. C., President and CEO, L. A. C. I., & Professor of Medicine, D. (2010) · European Endocrinology · doi:10.17925/ee.2013.09.01.40 · Cited by 167
Industry support and correlation to study outcome for papers published in Spine
Shah, R. V., Albert, T. J., Bruegel-Sanchez, V., Vaccaro, A. R., Hilibrand, A. S., & Grauer, J. N. (2005) · Spine · doi:10.1097/01.brs.0000161004.15308.b4 · Cited by 155
Medical Scientists and Health News Reporting: A Case of Miscommunication
Shuchman, M., & Wilkes, M. S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00008 · Cited by 149
Thyroid Hormone Replacement Therapy
Wiersinga, W. M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048140 · Cited by 150
Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
Azizi, F., Ataie, L., Hedayati, M., Mehrabi, Y., & Sheikholeslami, F. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01904 · Cited by 139
Industry Funding of Clinical Trials: Benefit or Bias?
Chopra, S. S. (2003) · JAMA · doi:10.1001/jama.290.1.113 · Cited by 127
Alternative Medications for Medications in the Use of High‐Risk Medications in the Elderly and Potentially Harmful Drug–Disease Interactions in the Elderly Quality Measures
Hanlon, J. T., Semla, T. P., & Schmader, K. E. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13807 · Cited by 130
Association Between Funding Source and Study Outcome in Orthopaedic Research
Leopold, S. S., Warme, W. J., Braunlich, E. F., & Shott, S. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093888.12372.d9 · Cited by 121
Treatment of hypothyroidism.
Hueston, W. J. (2001) · PubMed · Cited by 118
Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee
Blümle, A., Huwiler, K., & Witschi, M. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12027 · Cited by 114
Antimalarial drug quality in Africa
Amin, A. A., & Kokwaro, G. O. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00847.x · Cited by 84
Generic and Brand-Name l -Thyroxine Are Not Bioequivalent for Children With Severe Congenital Hypothyroidism
Carswell, J. M., Gordon, J. H., Popovsky, E., Hale, A., & Brown, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3125 · Cited by 83
Substitution of Liothyronine at a 1:5 Ratio for a Portion of Levothyroxine: Effect on Fatigue, Symptoms of Depression, and Working Memory Versus Treatment With Levothyroxine Alone
Rodriguez, T., Lavis, V. R., Meininger, J. C., Kapadia, A. S., & Stafford, L. F. (2005) · Endocrine Practice · doi:10.4158/ep.11.4.223 · Cited by 80
Diagnosis and treatment of levothyroxine pseudomalabsorption.
Lips, D. J., Reisen, M. V., Voigt, V., & Venekamp, W. J. R. R. (2004) · PubMed · Cited by 73
Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans
Fischer, M. A., & Avorn, J. (2003) · Health Services Research · doi:10.1111/1475-6773.00162 · Cited by 72
Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications: The Tort Bar and Editorial Oversight of Medical Journals
Hirsch, L. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.9.811 · Cited by 67
Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey
Kesselheim, A. S., Gagne, J. J., Franklin, J. M., Eddings, W., Fulchino, L. A., Avorn, J., & Campbell, E. G. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3612-7 · Cited by 67
Counterfeit drugs in Nigeria: A threat to public health
Akiny, O. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp12.343 · Cited by 66
Patients’ health or company profits? The commercialisation of academic research
Olivieri, N. F. (2003) · Science and Engineering Ethics · doi:10.1007/s11948-003-0017-x · Cited by 65
Industry-sponsored research
Okike, K. M., Kocher, M. S., Mehlman, C. T., & Bhandari, M. (2008) · Injury · doi:10.1016/j.injury.2008.02.013 · Cited by 62
Generic Drugs in the United States: Policies to Address Pricing and Competition
Gupta, R. M., Shah, N. D., & Ross, J. S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1314 · Cited by 59
Thyroxine and treatment of hypothyroidism: seven decades of experience
Mateo, R. C. I., & Hennessey, J. V. (2019) · Endocrine · doi:10.1007/s12020-019-02006-8 · Cited by 57
Can you believe what you read?
van Kolfschooten, F. (2002) · Nature · doi:10.1038/416360a · Cited by 64
Disorders of the Thyroid Gland
Pellitteri, P. K., Ing, S. W., & Jameson, B. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05283-2.00124-5 · Cited by 56
Disturbance of the Fetal Thyroid Hormone State Has Long-Term Consequences for Treatment of Thyroidal and Central Congenital Hypothyroidism
Kempers, M. J. E., van Trotsenburg, A. S. P., van Tijn, D. A., Bakker, E., Wiedijk, B. M., Endert, E., de Vijlder, J. J. M., & Vulsma, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0197 · Cited by 54
Management Practices Among Primary Care Physicians and Thyroid Specialists in the Care of Hypothyroid Patients
McDermott, M. T., Haugen, B. R., Lezotte, D. C., Seggelke, S. A., & Ridgway, E. C. (2001) · Thyroid · doi:10.1089/10507250152484592 · Cited by 53
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit
Fischer, M. A., & Avorn, J. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.872 · Cited by 53
The safety and efficacy of antithyroid drugs
Azizi, F. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.107 · Cited by 52
Strategies That Delay Market Entry of Generic Drugs
Vokinger, K. N., Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.4650 · Cited by 50
Generic substitution: issues for problematic drugs.
Henderson, J. D., & Esham, R. H. (2001) · PubMed · Cited by 47
Hormone Replacement After Thyroid and Parathyroid Surgery
Schäffler, A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0827 · Cited by 46
Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution
Benvenga, S., & Carlé, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01079-1 · Cited by 46
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine
Greene, J. A. (2010) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/jrq049 · Cited by 40
Levothyroxine: therapeutic use and regulatory issues related to bioequivalence
Wartofsky, L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.6.727 · Cited by 38
Conflicts of interest of editors of medical journals
Haque, W. Z., Minhajuddin, A., Gupta, A., & Agrawal, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197141 · Cited by 33
‘Not the full Monty’: a qualitative study of seniors’ perceptions of generic medicines in Western Australia
Bulsara, C., McKenzie, A., Sanfilippo, F. M., Holman, C. D. J., & Emery, J. (2010) · Australian Journal of Primary Health · doi:10.1071/py10006 · Cited by 33
Association between generic-to-generic levothyroxine switching and thyrotropin levels among US adults.
Brito, J. P., Deng, Y., Ross, J. S., Choi, N. H., Graham, D. J., Qiang, Y., Rantou, E., Wang, Z., Zhao, L., Shah, N. D., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0045 · Cited by 29
Substitution von Schilddrüsenhormonen
Gärtner, R., & Reincke, M. (2008) · Der Internist · doi:10.1007/s00108-008-2109-9 · Cited by 29
"Double blind, you are the weakest link -- goodbye!"
Devereaux, P. J. (2002) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.7.1.4 · Cited by 29
Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
Pater, C. (2004) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-5-8 · Cited by 28
Relevance of pharmacokinetics in narrow therapeutic index drugs
Benet, L. Z. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00083-4 · Cited by 28
Conflict of interest
Holmes, D. R., Firth, B. G., James, A., Winslow, R., Hodgson, P. K., Gamble, G. L., Popp, R. L., & Harrington, R. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.001 · Cited by 28
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
Takigawa, N., Ochi, N., Yamane, H., Hotta, K., Fujii, H., Isozaki, H., Honda, Y., Yamagishi, T., Kubo, T., Tanimoto, M., et al. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s71419 · Cited by 27
Levothyroxine a New Drug? Since When? How Could That Be?
Hennessey, J. (2003) · Thyroid · doi:10.1089/105072503321582088 · Cited by 29
Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer
Hannoush, Z. C., & Weiss, R. E. (2016) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10229 · Cited by 30
Estudo de adesão ao tratamento do hipotiroidismo
Bagattoli, R. M., Vaisman, M., Lima, J. S., & Ward, L. S. (2000) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302000000600006 · Cited by 25
The Challenges and Complexities of Thyroid Hormone Replacement
Kansagra, S. M., McCudden, C. R., & Willis, M. S. (2010) · Laboratory Medicine · doi:10.1309/lmb39th2fzgndgim · Cited by 25
The cardiopulmonary effects and quality of anesthesia after induction with alfaxalone in 2‐hydroxypropyl‐β‐cyclodextrin in dogs and cats: a systematic review
Chiu, K. W., Robson, S., Devi, J. L., Woodward, A. P., & Whittem, T. (2016) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12312 · Cited by 24
Assessing the bioequivalence of analogues of endogenous substances (‘endogenous drugs’): considerations to optimize study design
Dissanayake, S. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03585.x · Cited by 24
Evaluation of the Therapeutic Efficacy of Different Levothyroxine Preparations in the Treatment of Human Thyroid Disease
Klein, I. L., & Danzi, S. E. (2003) · Thyroid · doi:10.1089/10507250360731523 · Cited by 23
Assessment of Levothyroxine Sodium Bioavailability
Walter‐Sack, I., Clanget, C., Ding, R., Göggelmann, C., Hinke, V., Lang, M., Pfeilschifter, J., Tayrouz, Y., & Wegscheider, K. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443140-00006 · Cited by 20
Hormone replacement therapy in hypopituitarism
Smith, J. C. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.5.1023 · Cited by 20
Generic Levothyroxine Compared With Synthroid in Young Children With Congenital Hypothyroidism
Lomenick, J. P., Wang, L., Ampah, S. B., Saville, B. R., & Greenwald, F. I. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3558 · Cited by 19
An investigation into the influence of experimental conditions on in vitro drug release from immediate-release tablets of levothyroxine sodium and its relation to oral bioavailability
Kocic, I., Homsek, I., Dacevic, M., Parojcic, J., & Miljkovic, B. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9660-8 · Cited by 19
Patterns and Predictors of Generic Narrow Therapeutic Index Drug Use Among Older Adults
Gagne, J. J., Polinski, J. M., Kesselheim, A. S., Choudhry, N. K., Hutchins, D. S., Matlin, O. S., Tong, A., & Shrank, W. H. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12399 · Cited by 18
COMPARISON BETWEEN GENERIC DRUGS AND BRAND NAME DRUGS FROM BIOEQUIVALENCE AND THERMOEQUIVALENCE PROSPECTIVE
Arafat, M., Ahmed, Z., & Arafat, O. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i6.18735 · Cited by 18
Generic Warfarin
DeCara, J. M., Croze, S., & Falk, R. H. (1998) · CHEST Journal · doi:10.1378/chest.113.2.261 · Cited by 18
Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
Sarpatwari, A., Choudhry, N. K., Avorn, J., & Kesselheim, A. S. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001802 · Cited by 17
A cautionary tale: the dysfunction of American health care.
Poses, R. (2003) · European journal of internal medicine · doi:10.1016/s0953-6205(03)00029-3 · Cited by 14
Demystifying autoimmune thyroid disease
Fatourechi, V. (2000) · Postgraduate Medicine · doi:10.3810/pgm.2000.01.810 · Cited by 16
Bioequivalence of Levothyroxine Preparations: Industry Sponsorship and Academic Freedom
Eckert, C. H. (1997) · JAMA · doi:10.1001/jama.1997.03540390030021 · Cited by 16
Flumazenil: A Pharmacologic Antidote with Limited Medical Toxicology Utility, or … An Antidote in Search of an Overdose
Goldfrank, L. R. (1997) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1997.tb03653.x · Cited by 15
Increased fT4 concentrations in patients using levothyroxine without complete suppression of TSH
Jansen, H. I., Bult, M., Bisschop, P. H. L. T., Boelen, A., Heijboer, A. C., & Hillebrand, J. J. (2023) · Endocrine Connections · doi:10.1530/ec-22-0538 · Cited by 14
La declaración del conflicto de intereses en las publicaciones científicas. ¿Tiempo para las luces y los taquígrafos en la trastienda de la investigación financiada por la industria?
Peiró, S., García‐Altés, A., Meneu, R., Librero, J., & Bernal, E. (2000) · Gaceta Sanitaria · doi:10.1016/s0213-9111(00)71915-7 · Cited by 14
Double blind, you have been voted off the island!
Devereaux, P. J., Bhandari, M., Montori, V. M., Manns, B., Ghali, W. A., & Guyatt, G. H. (2002) · Evidence-Based Mental Health · doi:10.1136/ebmh.5.2.36 · Cited by 14
Bioequivalence of levothyroxine preparations for treatment of hypothyroidism.
Spigelman, M. (1997) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.1997.03540390029019 · Cited by 14
Review of Heterotopic Thyroid Autotransplantation
Sakr, M. F., & Mahmoud, A. (2017) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2016.01578 · Cited by 14
Hypothyroidism and Myxedema Coma
Wiersinga, W. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00085-x · Cited by 13
Emerging technologies in coloproctology: results of the Italian Society of Colorectal Surgery Logbook of Adverse Events
AECO Group, Basso, L., Pescatori, M., Torre, F. L., Destefano, I., d’Urso, A. P., Infantino, A., & Amato, A. (2012) · Techniques in Coloproctology · doi:10.1007/s10151-012-0906-6 · Cited by 12
Advertising Policies of Medical Journals: Conflicts of Interest for Journal Editors and Professional Societies
Orentlicher, D., & Hehir, M. K. (1999) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.1999.tb01443.x · Cited by 12
Financial Conflicts of Interest in the School Psychology Assessment Literature.
Truscott, S. D., Baumgart, M., & Rogers, K. (2004) · School Psychology Quarterly · doi:10.1521/scpq.19.2.166.33311 · Cited by 11
RESEARCH ETHICS IN EMERGENCY MEDICINE
Fish, S. S. (1999) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70072-9 · Cited by 12
Testing the Bioavailability of Oral L-Thyroxine by Studying Its Absorption: Smoke or Mirrors?
Stockigt, J. (2004) · Thyroid · doi:10.1089/105072504773297821 · Cited by 12
Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis
Ruggenthaler, M., Grass, J., Schuh, W., Huber, C. G., & Reischl, R. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.12.002 · Cited by 11
Thyroid disease: a review for primary care.
Larson, J., Anderson, E., & Koslawy, M. (2000) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2000.tb00186.x · Cited by 11
The Generic Imperative
Zarowitz, B. J. M. (2008) · Geriatric Nursing · doi:10.1016/j.gerinurse.2008.06.003 · Cited by 11
Paying the Piper for Pharmacoeconomic Studies
Neumann, P. J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s05 · Cited by 11
Review of current authorship guidelines and the controversy regarding publication of clinical trial data
Foote, M. (2003) · Biotechnology annual review · doi:10.1016/s1387-2656(03)09009-4 · Cited by 11
Advances on Hormones and Steroids Determination: A Review of Voltammetric Methods since 2000
Smajdor, J., Paczosa‐Bator, B., & Piech, R. (2022) · Membranes · doi:10.3390/membranes12121225 · Cited by 10
Reproducible pharmacokinetics
Ioannidis, J. P. A. (2019) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-019-09621-y · Cited by 10
Double blind, you are the weakest link ‐ goodbye!
Devereaux, P. J., Bhandari, M., Montori, V. M., Manns, B., Ghali, W. A., & Guyatt, G. H. (2005) · Equine Veterinary Journal · doi:10.2746/042516405775314916 · Cited by 10
The pharmaceutical industry: our 'silent' partner in the practice of medicine.
Anand, A. C. (2000) · PubMed · Cited by 10
Bioequivalence of endogenous substances facing homeostatic equilibria: an example with potassium
Marzo, A., Vuksic, D., & Crivelli, F. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0720 · Cited by 9
NHG-Standaard Schildklieraandoeningen
Wessels, P., van Rijswijk, E., Boer, M. A., & van Lieshout, J. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_86 · Cited by 9
Regulatory issues for Data and Safety Monitoring Committees
Fisher, L. D., & Klibaner, M. I. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113839 · Cited by 9

Authors: Dong, B. J.
Affiliations: University of California, San Francisco (US)
Corresponding author: Dong, Betty J.
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1997-04-16
Volume: 277
Issue: 15
Pages: 1205
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1997.03540390035032
OpenAlex: W2010621528
Cited by: 185
References: 24
Citations by year: 2024: 1 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 7
FWCI: 8.39
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
Keywords: levothyroxine, bioequivalence, generic drugs, brand-name drugs, hypothyroidism, thyroxine replacement, triiodothyronine, free thyroxine index, crossover trial
MeSH terms: Adult, Aged, Drug Industry, Female, Humans, Hypothyroidism, Middle Aged, Therapeutic Equivalency, Thyroid Function Tests, Thyrotropin, Thyroxine, Triiodothyronine, Drugs, Generic, Cross-Over Studies, Area Under Curve

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bioequivalence of Generic and Brand-name Levothyroxine Products in the Treatment of Hypothyroidism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks